Dropped head syndrome tied to rare MG with anti-MuSK antibodies
A 64-year-old woman with dropped head syndrome was found to have a form of MG with antibodies against MuSK, and weak spine muscles.| Myasthenia Gravis News
Rituximab is an antibody-based therapy that may be used off-label in patients with certain types of myasthenia gravis.| Myasthenia Gravis News
A 64-year-old woman with dropped head syndrome was found to have a form of MG with antibodies against MuSK, and weak spine muscles.| Myasthenia Gravis News
Muscle weakness and fatigue are hallmark symptoms of myasthenia gravis (MG), an autoimmune disorder. MG symptoms may come and go.| Myasthenia Gravis News
Myasthenia gravis occurs when self-reactive antibodies mistakenly attack the body's immune system, causing muscle weakness and fatigue.| Myasthenia Gravis News
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto...| Myasthenia Gravis News
Mestinon (pyridostigmine bromide) is an oral therapy approved for the treatment of myasthenia gravis (MG).| Myasthenia Gravis News
Generalized myasthenia gravis is a chronic autoimmune neuromuscular condition that causes muscle weakness in different parts of the body.| Myasthenia Gravis News
Category archive page for News.| Myasthenia Gravis News
Myasthenia gravis is a neuromuscular disease characterized by weakness and fatigue that can affect muscles involved in voluntary movements.| Myasthenia Gravis News
